NASDAQ:DRIO
DarioHealth Corp.
DarioHealth Corp.'s revenue fell 17.3% in fiscal 2025 to $22.4M while operating margin rose to −163.9%, its highest in 10 years. Free cash flow was −$26.1M, −116.7% of revenue, and the diluted share count rose 62.4%.Summary generated from DarioHealth Corp.'s SEC filings. Latest annual report filed Mar 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$22.4M
Revenue growth−17.3%
Revenue, 5-yr CAGR+24.2%
Gross margin56.6%
Operating margin−163.9%
Net margin−186.6%
ROIC−38.6%
Return on equity−59.6%
Debt / equity0.45
Free cash flow−$26.1M
FCF margin−116.7%
Share count change+62.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 21 | 28 | 20 | 27 | 22 |
| Operating income | −76 | −57 | −56 | −58 | −37 |
| Net income | −77 | −62 | −59 | −43 | −42 |
| Free cash flow | −51 | −48 | −31 | −39 | −26 |
Recent filings
- 4Insider transaction report
Sep 28, 2026 - 4Insider transaction report
Sep 28, 2026 - 8-KDirector or officer change
Sep 4, 2026 - 8-KDirector or officer change
Aug 21, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KEntry into a material agreement
Jul 22, 2026 - 8-KDirector or officer change
Jul 10, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026